Your strategic
partner for
protein biomarkers

Altheome is a biomarker and proteomics specialist advancing precision medicine through cutting-edge analytical platforms.

With expertise in ultrasensitive immunoassays and next-generation proteomics, Altheome delivers unmatched sensitivity and scale in biomarker measurement. We partner with pharmaceutical organisations, biotechnology companies, and academia to accelerate discovery, validate biomarkers, and translate insights into clinical impact. By bridging discovery and application, Altheome is shaping the future of biomarker-driven diagnostics and therapies.

Let’s collaborate >

End-to-end biomarker and proteomics CRO services

From assay development to data analysis and high-throughput sample processing, our team combines ultra-sensitive, world-class tools with deep expertise to tackle complex scientific challenges, accelerating discovery and delivering actionable insights.

We work closely with our partners throughout product development to deliver precise, reliable results you can trust. Exploring novel biomarker development or looking to commercialise testing for patients at scale?

We’re a collaborative CRO – your strategic partner, at every stage in the journey.

Our services

  • Ultra-sensitive proteomic biomarker panels

  • Technologies including Alamar NULISA, Quanterix SIMOA, and MSD electrochemiluminescence

  • Custom biomarker panels and assay development

  • Protocol optimisation

  • Adaptive biomarker discovery and validation strategies

  • PK/PD studies

  • Sample analysis and processing

  • Data analysis and interpretation

  • High-throughput assays and multiplexed solutions

  • Sequencing

  • Sample biobanking and logistics

  • Specialist expertise in oncology and brain, gut, inflammatory, and cardiovascular health

Explore our CRO services >

Latest news

Altheome at ImmunoMark Summit 2026
We are proud to share that Altheome will be participating in the ImmunoMark Summit 2026, taking place on 5-6 March 2026 in London, UK.
Read More > →
Altheome at ELRIG Drug Discovery 2025
We’re pleased to announce that Altheome will be sponsoring ELRIG Drug Discovery 2025, happening on 21–22 October 2025 in Liverpool, UK.
Read More > →

Contact the team

Start a conversation with our team and see what we can achieve together.

Let’s collaborate >